Holen Sie sich die Stockscreener-App
153.10
1.04%
1.58
Handel nachbörslich:
154.10
1.00
+0.65%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$151.52
Offen:
$151.68
24-Stunden-Volumen:
1.13M
Relative Volume:
1.42
Marktkapitalisierung:
$17.09B
Einnahmen:
$9.54B
Nettoeinkommen (Verlust:
$841.00M
KGV:
22.99
EPS:
6.66
Netto-Cashflow:
$1.02B
1W Leistung:
-1.23%
1M Leistung:
-5.10%
6M Leistung:
+10.78%
1J Leistung:
+13.60%
1-Tages-Spanne:
$151.68
$154.10
1-Wochen-Bereich:
$149.07
$156.53
52-Wochen-Spanne:
$123.04
$165.32
Quest Diagnostics Inc Stock (DGX) Company Profile
Firmenname
Quest Diagnostics Inc
Sektor
Branche
Telefon
(973) 520-2700
Adresse
500 PLAZA DRIVE, SECAUCUS
Vergleichen Sie DGX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
153.10 | 17.09B | 9.54B | 841.00M | 1.02B | 7.44 |
|
TMO
Thermo Fisher Scientific Inc
|
524.05 | 200.45B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
228.55 | 165.08B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
134.51 | 38.36B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.27 | 35.80B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
412.26 | 33.76B | 3.84B | 866.24M | 792.60M | 10.37 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | Fortgesetzt | Jefferies | Buy |
| 2024-10-23 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-08-28 | Fortgesetzt | Evercore ISI | In-line |
| 2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-02-07 | Hochstufung | Jefferies | Hold → Buy |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-12-12 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-06-29 | Eingeleitet | Piper Sandler | Neutral |
| 2023-05-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-04-03 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-01-23 | Eingeleitet | Evercore ISI | In-line |
| 2022-11-17 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-04-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-02-23 | Herabstufung | UBS | Buy → Neutral |
| 2022-02-02 | Herabstufung | Jefferies | Buy → Hold |
| 2022-01-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-05-04 | Hochstufung | UBS | Neutral → Buy |
| 2021-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-10-21 | Hochstufung | Argus | Hold → Buy |
| 2020-07-29 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-14 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-06-09 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2020-06-02 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-04-28 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-27 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-04-27 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-03-27 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-01-07 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-12-19 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-07-15 | Herabstufung | Goldman | Neutral → Sell |
| 2019-04-02 | Hochstufung | Jefferies | Hold → Buy |
| 2019-03-18 | Fortgesetzt | Credit Suisse | Neutral |
| 2019-01-31 | Herabstufung | Argus | Buy → Hold |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2019-01-03 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2018-11-30 | Herabstufung | Goldman | Buy → Neutral |
Alle ansehen
Quest Diagnostics Inc Aktie (DGX) Neueste Nachrichten
StockNews.com Upgrades Quest Diagnostics (NYSE:DGX) to "Buy" - MarketBeat
Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch
Quest Diagnostics (NYSE:DGX) Stock Quotes, Forecast and News Summary - Benzinga
Quest Diagnostics to Speak at the 7th Annual Evercore HealthCONx Conference - The Eastern Progress Online
Quest Diagnostics Launches Health Coaching on questhealth.com to Help Individuals Take Control of Their Health - The Eastern Progress Online
Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test - GlobeNewswire Inc.
Mainz Biomed N.V. Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test - Marketscreener.com
Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Sanctuary Advisors LLC Raises Stock Position in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Advances Green Initiative: 40M kWh Renewable Energy, Major CO2 Cuts in Sustainability Push - StockTitan
Morgan Stanley Upgrades Quest Diagnostics (NYSE:DGX) to Overweight - MarketBeat
Quest Diagnostics upgraded by Morgan Stanley with a new price target - Quantisnow
Quest Diagnostics Inc. stock outperforms competitors despite losses on the day - MarketWatch
Quest Diagnostics (NYSE:DGX) Price Target Raised to $182.00 at Bank of America - MarketBeat
Geode Capital Management LLC Boosts Stock Position in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Cell Free DNA (cfDNA) Testing Market Outlook to 2028 & 2033 - GlobeNewswire Inc.
Barclays PLC Raises Position in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Public Employees Retirement System of Ohio Sells 5,694 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Prices $1.85 Billion of Senior Notes - The Eastern Progress Online
Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Quest Diagnostics (NYSE:DGX) Given "Buy" Rating at Jefferies Financial Group - MarketBeat
SGL Investment Advisors Inc. Invests $4.17 Million in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Worldquant Millennium Advisors LLC Sells 60,961 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics | The Power List - NJBIZ
State Street Corp Purchases 70,578 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Shares Sold by Wellington Management Group LLP - MarketBeat
Quadrature Capital Ltd Has $812,000 Stock Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Benjamin Edwards Inc. Invests $678,000 in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Completes Acquisition of LifeLabs, Enhancing Access to Diagnostic Innovation - The Eastern Progress Online
Quest Diagnostics Declares Quarterly Cash Dividend - The Eastern Progress Online
Integrated Wealth Concepts LLC Buys 4,241 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Stock Position Lessened by Holocene Advisors LP - MarketBeat
New Health Coaching Service on questhealth.com Set to Boost DGX Stock - MSN
Chevy Chase Trust Holdings LLC Purchases 11,496 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Rockefeller Capital Management L.P. Buys 10,903 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Unveils Advanced Cybersecurity Framework to Safeguard Patient Data Privacy - StockTitan
DGXQuest Diagnostics Inc. Latest Stock News & Market Updates - StockTitan
55,000 Shares in Quest Diagnostics Incorporated (NYSE:DGX) Bought by Parkman Healthcare Partners LLC - MarketBeat
Caisse DE Depot ET Placement DU Quebec Has $273,000 Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Fortifies Patient Data Privacy and Cybersecurity With Robust Safeguards and Ongoing Threat Mitigation Strategies - Marketscreener.com
Analysts Set Quest Diagnostics Incorporated (NYSE:DGX) Price Target at $164.58 - MarketBeat
Fecal Immunochemical Diagnostic Test (FIT) Market Key Players - openPR
Which GCs Sold Stock In November? Quest, Exelixis, More - Law360
Cinctive Capital Management LP Invests $4.28 Million in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Fmr LLC Sells 127,281 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Launches Personalized Health Coaching Service, Expands Digital Health Offerings - StockTitan
Quest Diagnostics SVP sells $5.73m in stock By Investing.com - Investing.com Nigeria
Quest Diagnostics SVP sells $5.73m in stock - Investing.com India
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Cuts Position in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Is Now The Time To Look At Buying Quest Diagnostics Incorporated (NYSE:DGX)? - Simply Wall St
Quest Diagnostics Incorporated (NYSE:DGX) Stock Holdings Lifted by Zurcher Kantonalbank Zurich Cantonalbank - MarketBeat
Finanzdaten der Quest Diagnostics Inc-Aktie (DGX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):